Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Common Equity: 2009-2024

Historic Common Equity for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $419.0 million.

  • Cross Country Healthcare's Common Equity fell 389.67% to $408.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.1 million, marking a year-over-year decrease of 389.67%. This contributed to the annual value of $419.0 million for FY2024, which is 1041.2% down from last year.
  • Per Cross Country Healthcare's latest filing, its Common Equity stood at $419.0 million for FY2024, which was down 1041.2% from $467.7 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Common Equity peaked at $467.7 million during FY2023, and registered a low of $154.9 million during FY2020.
  • Its 5-year average for Common Equity is $358.1 million, with a median of $419.0 million in 2024.
  • Per our database at Business Quant, Cross Country Healthcare's Common Equity soared by 9206.63% in 2021 and then crashed by 1041.2% in 2024.
  • Cross Country Healthcare's Common Equity (Annual) stood at $154.9 million in 2020, then surged by 92.07% to $297.5 million in 2021, then soared by 51.74% to $451.5 million in 2022, then rose by 3.58% to $467.7 million in 2023, then decreased by 10.41% to $419.0 million in 2024.
  • Its Common Equity stands at $419.0 million for FY2024, versus $467.7 million for FY2023 and $451.5 million for FY2022.